Strategic partnerships Leverage recent collaborations with Prolight Diagnostics and Oragenics to pitch integrated diagnostic and point-of-care testing solutions for mild traumatic brain injury, emphasizing joint test-to-treat capabilities and potential co-marketing opportunities.

Leadership expansion Target outreach to the newly appointed Chief Product and Commercial Officer to understand roadmap priorities, potential pilot programs, and funding needs for commercializing multi-modality TBI diagnostics.

Clinical validation Highlight ongoing clinical and prognostic test program progress to hospital systems and labs, offering pilot studies and real-world data collaborations that demonstrate diagnostic accuracy and patient outcome improvements.

POC and lab integration Position the multi-modality platform as compatible with both point-of-care instruments and standard laboratory systems to attract ambulatory centers, urgent care networks, and hospital labs seeking flexible deployment.

Funding and momentum Capitalize on existing funding and venture support from Virginia Venture Partners to approach regional health systems and research institutions with co-investment and grant-ready opportunities aligned with targeted TBI workflows.